Table of Content

1. Introduction


2. Research Methodology


3. Executive Summary


4. Market Dynamics

4.1 Growth Drivers
4.2 Challenges


5. Global Prostate Cancer Diagnostics Market


6. Global Prostate Cancer Diagnostics Market Share Analysis

6.1 Type
6.2 Test Type
6.3 End User
6.4 Country


7. Type – Global Prostate Cancer Diagnostics Market

7.1 Benign Prostatic Hyperplasia
7.2 Prostatic Adenocarcinoma
7.3 Small Cell Carcinoma
7.4 Others


8. Test Type – Global Prostate Cancer Diagnostics Market

8.1 Preliminary Tests
8.2 Confirmatory Tests


9. End User – Global Prostate Cancer Diagnostics Market

9.1 Hospitals
9.2 Diagnostic Centers
9.3 Research Institutes
9.4 Others


10. Country – Global Prostate Cancer Diagnostics Market

10.1 North America

10.1.1 United States
10.1.2 Canada

10.2 Europe

10.2.1 France
10.2.2 Germany
10.2.3 Italy
10.2.4 Spain
10.2.5 United Kingdom
10.2.6 Belgium
10.2.7 Netherlands
10.2.8 Turkey

10.3 Asia Pacific

10.3.1 China
10.3.2 Japan
10.3.3 India
10.3.4 South Korea
10.3.5 Thailand
10.3.6 Malaysia
10.3.7 Indonesia
10.3.8 Australia
10.3.9 New Zealand

10.4 Latin America

10.4.1 Brazil
10.4.2 Mexico
10.4.3 Argentina

10.5 Middle East & Africa

10.5.1 Saudi Arabia
10.5.2 UAE
10.5.3 South Africa


11. Porter’s Five Analysis – Global Prostate Cancer Diagnostics Market

11.1 Bargaining Power of Buyers
11.2 Bargaining Power of Suppliers
11.3 Degree of Rivalry
11.4 Threat of New Entrants
11.5 Threat of Substitutes


12. SWOT Analysis – Global Prostate Cancer Diagnostics Market

12.1 Strength
12.2 Weakness
12.3 Opportunity
12.4 Threat


13. Key Players

13.1 F. Hoffman-La Roche AG

13.1.1 Overview
13.1.2 Recent Development
13.1.3 Product Portfolio & Product Launch in Last 1 Year
13.1.4 Revenue

13.2 Bayer AG

13.2.1 Overview
13.2.2 Recent Development
13.2.3 Product Portfolio & Product Launch in Last 1 Year
13.2.4 Revenue

13.3 Thermo Fisher Scientific Inc.

13.3.1 Overview
13.3.2 Recent Development
13.3.3 Product Portfolio & Product Launch in Last 1 Year
13.3.4 Revenue

13.4 Abbott Laboratories Inc.

13.4.1 Overview
13.4.2 Recent Development
13.4.3 Product Portfolio & Product Launch in Last 1 Year
13.4.4 Revenue

13.5 Siemens Healthineers AG

13.5.1 Overview
13.5.2 Recent Development
13.5.3 Product Portfolio & Product Launch in Last 1 Year
13.5.4 Revenue

13.6 Becton Dickinson and Company

13.6.1 Overview
13.6.2 Recent Development
13.6.3 Product Portfolio & Product Launch in Last 1 Year
13.6.4 Revenue

13.7 Agilent Technologies Inc.

13.7.1 Overview
13.7.2 Recent Development
13.7.3 Product Portfolio & Product Launch in Last 1 Year
13.7.4 Revenue

13.8 Hologic Inc

13.8.1 Overview
13.8.2 Recent Development
13.8.3 Product Portfolio & Product Launch in Last 1 Year
13.8.4 Revenue

13.9 Qiagen N.V.

13.9.1 Overview
13.9.2 Recent Development
13.9.3 Product Portfolio & Product Launch in Last 1 Year
13.9.4 Revenue

13.10 OPKO Health Inc.

13.10.1 Overview
13.10.2 Recent Development
13.10.3 Product Portfolio & Product Launch in Last 1 Year
13.10.4 Revenue